Search by Drug Name or NDC

    NDC 24979-0247-06 Forfivo 450 mg/1 Details

    Forfivo 450 mg/1

    Forfivo is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TWi Pharmaceuticals, Inc.. The primary component is BUPROPION HYDROCHLORIDE.

    Product Information

    NDC 24979-0247
    Product ID 24979-247_87ba21ae-96ae-4ebd-b7d1-dd349e370b21
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Forfivo
    Proprietary Name Suffix XL
    Non-Proprietary Name bupropion hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 450
    Active Ingredient Units mg/1
    Substance Name BUPROPION HYDROCHLORIDE
    Labeler Name TWi Pharmaceuticals, Inc.
    Pharmaceutical Class Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022497
    Listing Certified Through 2024-12-31

    Package

    NDC 24979-0247-06 (24979024706)

    NDC Package Code 24979-247-06
    Billing NDC 24979024706
    Package 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-247-06)
    Marketing Start Date 2023-12-15
    NDC Exclude Flag N
    Pricing Information N/A